Please login to the form below
suspension
This page shows the latest suspension news and features for those working in and with pharma, biotech and healthcare.
FDA rejects Takeda’s Eohilia after delays
After more than a year on ‘priority review’, the FDA has said it cannot approve Takeda’s budesonide oral suspension without a further clinical study. ... Takeda has received a Complete Response Letter from the US Food and Drug Administration (FDA)
Latest news
-
bluebird bio to restart marketing of Zynteglo in EU after previous suspension
EMA’s safety committee PRAC has confirmed favourable risk-benefit balance of gene therapy
-
EU considers blocking COVID-19 vaccine exports to the UK
vaccines. The suspension of the AZ/Oxford vaccine by a number of EU countries, following reports of suspected blood clots in some who have received the vaccine, has hindered the
-
EU announces ‘top-up’ of ten million Pfizer/BioNTech vaccines in Q2
vaccines. The suspension of the AZ/Oxford vaccine by a number of EU countries, following reports of suspected blood clots in people vaccinated with the jab, has hindered the EU's
-
EMA says there is ‘no indication’ AZ/Oxford’s COVID-19 vaccine causes blood clots
Other EU member states – Italy and Austria – have suspended vaccination from certain batches of the vaccine, although the suspensions in each country involves different batches. ... The suspensions come as a ‘precautionary measure’, the EMA said
-
bluebird bio posts modest Q4 revenue growth as it continues investigation into troubled LentiGlobin
The suspension comes after a reported suspected unexpected serious adverse reaction (SUSAR) of acute myeloid leukaemia and a separate SUSAR of myelodysplastic syndrome in the company’s HGB-206 study.
More from news
Approximately 3 fully matching, plus 135 partially matching documents found.
Latest Intelligence
-
Risks, reforms and rewards: the evolving Russian healthcare market
The period also saw male life expectancy fall, various diseases re-emerge and the suspension of immunisation programmes in various parts of the country.
-
Cell and gene therapy
One example is Lonza’s use of 2000L suspension cultures for viral vector manufacturing instead of traditional 2D methods, which the firm says has significantly improved efficiency.
-
Significant figures
ALIS (Amikacin liposome inhalation suspension) is being developed as a treatment for refractory non tuberculous Mycobacterial (NTM) lung disease, a rare progressive, destructive infection caused by mycobacterium avium complex.
-
Gene therapy
GalNAc technology does hold potential, but has limited utility, and a recent trial suspension using this technology has not yet been fully resolved.
-
Deal Watch July 2016
Other deals where the licensee has committed real upfront money include Takeda's $28m upfront payment for ex-US rights to TiGenix's Cx601, a suspension of allogeneic adipose-derived stem
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Mirna hires former Pfizer director as CMO
liposome injectable suspension).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: What's missing in women's health?
SAYANA PRESS 104 mg/0.65 ml suspension for injection – Summary of. ... 10. Sayana Press UK Supply Issue (medroxyprogesterone acetate 104mg/0.65ml suspension for injection in the UnijectTM injection system).
-
How has the pandemic reshaped the NHS in 2020?
Funding. One of the most significant financial changes was the suspension of payment by results (PbR), and the announcement that all NHS trusts and foundation trusts would move to block contract
-
The impact of 5G on digital marketing
on smooth, flawless execution to maintain the suspension of disbelief to truly dazzle consumers.
-
Could coronavirus turn us all into online gamers?
As businesses gauge the potential impact of coronavirus (COVID-19), with a sense of fear and pessimism causing a dampening of economic activity and suspension of the stock market, the healthcare
-
Page & Page and Partners
As businesses gauge the potential impact of coronavirus (COVID-19), with a sense of fear and pessimism causing a dampening of economic activity and suspension of the stock market, the healthcare
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- How pharma found its voice – health communications for a brave new world
- The importance of beliefs in creative health engagement
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
